11-57794071-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001085458.2(CTNND1):āc.257A>Gā(p.Asn86Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,613,996 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. N86N) has been classified as Likely benign.
Frequency
Consequence
NM_001085458.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CTNND1 | NM_001085458.2 | c.257A>G | p.Asn86Ser | missense_variant | 4/21 | ENST00000399050.10 | |
TMX2-CTNND1 | NR_037646.1 | n.816A>G | non_coding_transcript_exon_variant | 5/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CTNND1 | ENST00000399050.10 | c.257A>G | p.Asn86Ser | missense_variant | 4/21 | 1 | NM_001085458.2 |
Frequencies
GnomAD3 genomes AF: 0.00102 AC: 155AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00122 AC: 301AN: 246852Hom.: 2 AF XY: 0.00119 AC XY: 160AN XY: 134144
GnomAD4 exome AF: 0.00109 AC: 1586AN: 1461678Hom.: 4 Cov.: 31 AF XY: 0.00109 AC XY: 791AN XY: 727128
GnomAD4 genome AF: 0.00102 AC: 155AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000940 AC XY: 70AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | CTNND1: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
CTNND1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at